Cargando…

Fluoroscopic Characterization of Colonic Dysmotility Associated to Opioid and Cannabinoid Agonists in Conscious Rats

BACKGROUND/AIMS: Gastrointestinal adverse effects have a major impact on health and quality of life in analgesics users. Non-invasive methods to study gastrointestinal motility are of high interest. Fluoroscopy has been previously used to study gastrointestinal motility in small experimental animals...

Descripción completa

Detalles Bibliográficos
Autores principales:	Díaz-Ruano, Susana, López-Pérez, Ana E, Girón, Rocío, Pérez-García, Irene, Martín-Fontelles, María I, Abalo, Raquel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Neurogastroenterology and Motility 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474695/ https://www.ncbi.nlm.nih.gov/pubmed/30870877 http://dx.doi.org/10.5056/jnm18202

Ejemplares similares

Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal Dysmotility in the Rat
por: Vera, Gema, et al.
Publicado: (2017)

Effect of the Cannabinoid Agonist WIN 55,212-2 on Neuropathic and Visceral Pain Induced by a Non-Diarrheagenic Dose of the Antitumoral Drug 5-Fluorouracil in the Rat
por: Vera, Gema, et al.
Publicado: (2023)

Colonic Dysmotility in Murine Partial Colonic Obstruction Due to Functional Changes in Interstitial Cells
por: Wang, Qianqian, et al.
Publicado: (2019)

Dysmotility in Eosinophilic Esophagitis
por: Chai, Charmaine, et al.
Publicado: (2022)

Platelet-activating factor mediates trinitrobenzene induced dysmotility in the left colon
por: Longo, W. E., et al.
Publicado: (1995)

Chronic Constipation in the Elderly: An Unusual Presentation of Colonic Dysmotility in an Elderly Patient
por: Peravali, R., et al.
Publicado: (2013)

Downregulation of ICCs and PDGFRα+ cells on colonic dysmotility in hirschsprung disease
por: Gu, Aiming, et al.
Publicado: (2023)

PM287. Mixtures of opioid receptor agonists and cannabinoid receptor agonists: enhanced antinociception without abuse liability
por: France, Charles P, et al.
Publicado: (2016)

High-resolution colonic manometry and its clinical application in patients with colonic dysmotility: A review
por: Li, Yu-Wei, et al.
Publicado: (2019)

Role of oxidative stress in oxaliplatin‐induced enteric neuropathy and colonic dysmotility in mice
por: McQuade, Rachel M, et al.
Publicado: (2016)

Colonic Pseudo-obstruction With Transition Zone: A Peculiar Eastern Severe Dysmotility
por: Song, Eun Mi, et al.
Publicado: (2019)

Diagnosis of colonic dysmotility associated with autonomic dysfunction in patients with chronic refractory constipation
por: Liu, Lijun, et al.
Publicado: (2022)

The Enteric Glia and Its Modulation by the Endocannabinoid System, a New Target for Cannabinoid-Based Nutraceuticals?
por: López-Gómez, Laura, et al.
Publicado: (2022)

Esophageal Dysmotility in Gillespie Syndrome
por: Dell'Acqua Cassão, Bruna, et al.
Publicado: (2013)

Effect of visfatin on K(ATP) channel upregulation in colonic smooth muscle cells in diabetic colon dysmotility
por: Yu, Ting, et al.
Publicado: (2022)

Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain
por: Yuill, Matthew B, et al.
Publicado: (2017)

Colonic dysmotility and morphological abnormality frequently detected in Japanese patients with irritable bowel syndrome
por: Mizukami, Takeshi, et al.
Publicado: (2017)

A235 EFFECTS OF SACRAL PHOTOBIOMODULATION ON THE AUTONOMIC NERVOUS SYSTEM IN PATIENTS WITH COLONIC DYSMOTILITY
por: Chen, J, et al.
Publicado: (2021)

New Insights into the Understanding of Gastrointestinal Dysmotility
por: Ohlsson, Bodil, et al.
Publicado: (2007)

Hirschsprung's disease - Postsurgical intestinal dysmotility
por: Romaneli, Mariana Tresoldi das Neves, et al.
Publicado: (2016)

Ileostomy Prolapse in Children with Intestinal Dysmotility
por: Sparks, Eric A., et al.
Publicado: (2017)

Gastrointestinal dysmotility in critically ill patients
por: Ladopoulos, Theodoros, et al.
Publicado: (2018)

Gallbladder Volume Indicated for Gallbladder Dysmotility
por: Liu, Linlin, et al.
Publicado: (2017)

Cannabinoid Drugs-Related Neuroprotection as a Potential Therapeutic Tool Against Chemotherapy-Induced Cognitive Impairment
por: Boullon, Laura, et al.
Publicado: (2021)

The Implication of Gastric Dysmotility in the Pathophysiology of Functional Dyspepsia
por: Min, Yang Won
Publicado: (2017)

Dysmotility in Esophageal Atresia: Pathophysiology, Characterization, and Treatment
por: Faure, Christophe, et al.
Publicado: (2017)

Recent Advances in the Management of Severe Gastrointestinal Dysmotility
por: Vasant, Dipesh H, et al.
Publicado: (2021)

The Mechanisms for the Association of Cancer and Esophageal Dysmotility Disorders
por: Tustumi, Francisco, et al.
Publicado: (2021)

Dose-dependent Action of Zingiber officinale on Colonic Dysmotility and Ex Vivo Spontaneous Intestinal Contraction Modulation
por: Abidi, Chaima, et al.
Publicado: (2022)

Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
por: Finlay, David B., et al.
Publicado: (2022)

Opioid-induced short-term consciousness improvement in patients with disorders of consciousness
por: Ge, Qianqian, et al.
Publicado: (2023)

Synthetic cannabinoids use in a sample of opioid-use disorder patients
por: Alías-Ferri, María, et al.
Publicado: (2022)

Cannabinoids: A New Group of Agonists of PPARs
por: Sun, Yan, et al.
Publicado: (2007)

Prodromal Intestinal Events in Alzheimer’s Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition
por: Pellegrini, Carolina, et al.
Publicado: (2020)

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB(2) receptor
por: Patel, Monica, et al.
Publicado: (2023)

Quantitative analysis of opioids and cannabinoids in wastewater samples
por: Jacox, Alethea, et al.
Publicado: (2017)

Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases
por: Kienzl, Melanie, et al.
Publicado: (2020)

Shugan Decoction Alleviates Colonic Dysmotility in Female SERT-Knockout Rats by Decreasing M(3) Receptor Expression
por: Wang, Yinshu, et al.
Publicado: (2020)

Interaction between the Renin–Angiotensin System and Enteric Neurotransmission Contributes to Colonic Dysmotility in the TNBS-Induced Model of Colitis
por: Ferreira-Duarte, Mariana, et al.
Publicado: (2021)

Mast Cells and Gastrointestinal Dysmotility in the Cystic Fibrosis Mouse
por: De Lisle, Robert C., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_vprn19ealutqpt481o3a5s3rb5